These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Novo Nordisk A/S and Eli Lilly & Co ... ramp up next year when cheaper alternative versions of semaglutide — the active ingredient in Novo’s Wegovy — launch after semaglutide’s China patent expires.

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, ...